Back to Authors

Marianski, Sylwia

A5007324049 | I128902783

Mayo Clinic

Midwestern University

Citations 3

Iohexol-Measured Glomerular Filtration Rate and Urinary Biomarker Changes between Vancomycin and Vancomycin Plus Piperacillin-Tazobactam in a Translational Rat Model

Antimicrobial Agents and Chemotherapy | July 10, 2023 | Volume: 67 | Issue: 8 | Pages: No page available

10.1128/aac.00304-23 | PMID 37428202

Recent clinical studies have reported additive nephrotoxicity with the combination of vancomycin and piperacillin-tazobactam. However, preclinical models have failed to replicate this finding.
Nephrotoxin Stewardship Alongside Antimicrobial Stewardship

Clinical Infectious Diseases | December 23, 2022 | Volume: 76 | Issue: 8 | Pages: 1521-1522

10.1093/cid/ciac958 | PMID 36550021

Glomerular Function and Urinary Biomarker Changes between Vancomycin and Vancomycin plus Piperacillin-Tazobactam in a Translational Rat Model

Antimicrobial Agents and Chemotherapy | January 10, 2022 | Volume: 66 | Issue: 3 | Pages: No page available

10.1128/aac.02132-21 | PMID 35007142

Clinical studies have reported additive nephrotoxicity associated with the combination of vancomycin (VAN) and piperacillin-tazobactam (TZP). This study assessed differences in glomerular filtration rate (GFR) and urinary biomarkers between rats receiving VAN and those receiving VAN + TZP.